<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://innovox.news/news/second-circuit-ssc-arcesium-software-trade-secrets</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-04</news:publication_date>
      <news:title>Second Circuit revives SS&amp;C software case and clarifies confidential sharing of trade secrets</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/drax-ai-data-centre-100mw-tenant-conditions</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-03</news:publication_date>
      <news:title>Drax’s £20 billion AI data-centre plan starts at 100 MW—and still needs a tenant</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/eu-court-adviser-gemini-press-publisher-rights</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-03</news:publication_date>
      <news:title>Gemini’s live news answers may infringe publisher rights, EU court adviser says</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/federal-circuit-google-sonos-encryption-patent</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-03</news:publication_date>
      <news:title>Sonos defeats Google’s encryption patent appeal as claim language narrows the fight</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/fda-priority-review-uniqure-huntington-gene-therapy</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02</news:publication_date>
      <news:title>FDA accepts uniQure’s Huntington’s gene therapy for priority review—but the evidence remains unsettled</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/marvell-lumentum-ai-optical-connectivity-deal</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02</news:publication_date>
      <news:title>Marvell’s $115 billion Lumentum deal puts optical links at the center of the AI buildout</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://innovox.news/news/upc-invalidates-enanta-paxlovid-patent</loc>
    <news:news>
      <news:publication>
        <news:name>INNOVOX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02</news:publication_date>
      <news:title>UPC invalidates Enanta’s Paxlovid patent across 18 states—but its reasoning is not public</news:title>
    </news:news>
  </url>
</urlset>